On July 23, the FDAs Pharmacy Compounding Advisory Committee (PCAC) voted to recommend adding BPC-157 to the list of bulk drug substances that may be used by state-licensed compounding pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act

Detailed stages of the cycle: CPT-1 (outer mitochondrial membrane): Acyl-CoA + L-carnitine Acyl-carnitine + CoA-SH Rate limiting enzyme Inhibited by malonyl-CoA Isoforms: CPT-1A (liver), CPT-1B (muscle), CPT-1C (brain) CACT (translocase): Transport of acylcarnitine into the matrix Antiport with free carnitine The only transporter for acylcarnitines CPT-2 (inner mitochondrial membrane): Acyl-carnitine + CoA-SH Acyl-CoA + L-carnitine Regeneration of acyl-CoA in the matrix Not regulated by malonyl-CoA -oxidation (matrix): Cyclic shortening of the acyl chain Products: acetyl-CoA, FADH2, NADH CPT-1 regulation Research on Cell Cultures L-carnitine tested on various cell types: Cardiomyocytes: main source of energy from -oxidation Myotubes (C2C12): skeletal muscle metabolism Hepatocytes: ketogenesis and gluconeogenesis Adipocytes: lipolysis and lipid metabolism Cancer cells: Warburg metabolism vs

Explore LONGEVITY + CLINICAL Longevity and advanced functional medicine protocols For clients who want a broader Eden plan around longevity, hormone optimization, neuro-recovery, social stress, migraine-pattern support, and cellular aging
Overall, constipation in patients taking GLP-1 receptor agonists is common, predictable, and manageable